Receptor-mediated protection of normal hepatocytes during chemotherapy for hepatocellular carcinoma.
Keegan-Rogers
V
V
University of Connecticut School of Medicine, Farmington.
Wu
C H
CH
Wu
G Y
GY
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D037263:Asialoglycoprotein Receptor; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D002478:Cells, Cultured; D005688:Galactosamine / Q000633:toxicity; D006801:Humans; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D008113:Liver Neoplasms / Q000188:drug therapy*; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy*; D011971:Receptors, Immunologic / Q000187:drug effects / Q000502:physiology*
D000970:Antineoplastic Agents; D037263:Asialoglycoprotein Receptor; D011971:Receptors, Immunologic; D005688:Galactosamine